OrganiGram Holdings Inc. (OGI) News

OrganiGram Holdings Inc. (OGI): $1.20

0.05 (+4.35%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter OGI News Items

OGI News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

OGI News Highlights

  • OGI's 30 day story count now stands at 10.
  • Over the past 23 days, the trend for OGI's stories per day has been choppy and unclear. It has oscillated between 1 and 4.
  • HEXO, TSE and ACB are the most mentioned tickers in articles about OGI.

Latest OGI News From Around the Web

Below are the latest news stories about Organigram Holdings Inc that investors may wish to consider to help them evaluate OGI as an investment opportunity.

7 Top Marijuana Penny Stocks To Buy Before Optimism Ignites Again

Marijuana penny stocks may rally violently if optimism returns to the cannabis industry.

Brian Paradza, CFA on InvestorPlace | February 25, 2022

Cannabis Movers & Shakers: MedMen, Organigram, NeonMind, Green Check Verified

Former Tilray Exec Ana Bowman Joins MedMen As CFO MedMen Enterprises Inc . (CSE: MMEN) (OTCQX: MMNFF ) has appointed Ana Bowman as a chief financial officer, effective February 22. Bowman will succeed outgoing interim CFO Reece Fulgham, who will be returning to consulting firm SierraConstellation Partners. Bowman brings years of cannabis industry expertise, having served as vice president of financial reporting and FP&A of Tilray Brands (NASDAQ: TLRY ) (TSX:TLRY). Prior to joining Tilray, Bowman served as corporate controller of several publicly-traded U.S. registrants, following an exit from the world of big four public accounting. "We are excited to have Ana join as our permanent CFO — bringing with her significant financial expertise from her time at Tilray and large public accountin...

Benzinga | February 24, 2022

Organigram Holdings Inc. Announces Election of Directors

MONCTON, New Brunswick, February 24, 2022--Organigram Holdings Inc. ("Organigram" or the "Corporation") (TSX: OGI) (NASDAQ: OGI) announced today the results of voting at its annual meeting of shareholders held on February 23, 2022 (the "Meeting").

Yahoo | February 24, 2022

Why Canopy Growth, Hexo, and OrganiGram Are Slumping Today

Canadian marijuana stocks are reversing course Monday after last week''s industrywide surge higher.

The Motley Fool | February 14, 2022

Organigram Reports Highest Quarterly Net Revenue Ever In Q1, Remains Among Top Canadian Cannabis LPs

Cannabis company Organigram Holdings Inc. (NASDAQ: OGI ) (TSX: OGI) announced its results for the first quarter ended November 30, 2021. “Our r ecord-breaking results in the first quarter of fiscal 2022 are a testament to our successful strategy to create innovative, high-quality products that align with the evolving preferences of the various segments of cannabis consumers,” Beena Goldenberg, the company’s CEO, said. “Our positive outlook for 2022 is further bolstered by the addition of Laurentian’s premium products to our portfolio, with an increased presence in Quebec and the resumption of international sales, which will continue through the year.” Q1 2022 Financial Highlights Compared to the prior year, net revenue increased 57% to $30.4 million, from $19.3 million in the first quar...

Benzinga | February 11, 2022

Benzinga Interview: Organigram CEO Beena Goldenberg Discusses Company Performance And Canadian Cannabis Market

OrganiGram Holdings Inc (NASDAQ: OGI ) (TSE: OGI) CEO Beena Goldenberg recently spoke with Benzinga to discuss the company''s ongoing growth and Q2 success. Crediting the team for persevering during the pandemic, the CEO said Organigram is focusing on utilizing its recent success to further establish itself across Canada''s markets and various buyers. Continuing Strong Performances In Early 2022 Goldenberg told Benzinga that Organigram has substantial momentum in early 2022, noting a market share increase that grew from 4.4% in Q1 2021 to 7.5% the same period this year. Among the factors making the previous quarter a success were the company''s two value brands: the milled flower Shred and the 28-gram offering Bag o'' Buds . Goldenberg credits product consistency and price points helpin...

Benzinga | February 11, 2022

Despite Market Headwinds, Organigram Is Making Progress Toward Its Goals

Like most marijuana stocks, Organigram (NASDAQ: OGI) has underperformed the market in recent years, but in its most recent fiscal first quarter, the company showed off strong growth and a narrowing loss on the bottom line. In this episode of "Beat and Raise" recorded on Jan. 21, Fool contributors Rachel Warren and Brian Withers discuss Organigram's prospects and what makes it unique. Rachel Warren: Yeah, this is interesting.

Yahoo | February 4, 2022

Why Marijuana Stocks Are Smoking Hot Today

Marijuana stocks are having a terrific Tuesday, with OrganiGram Holdings (NASDAQ: OGI) shares gaining 8% as of 11:35 a.m. ET, Aurora Cannabis (NASDAQ: ACB) up a strong 9%, and Hexo Corp (NASDAQ: HEXO) leading the whole pack higher with a 12.8% gain. You can thank Senate Majority Leader Chuck Schumer for that. The only actual stock-specific news for this bunch today concerns Hexo, which yesterday announced that the Nasdaq Stock Market has issued it a "compliance with the minimum bid price requirement," warning Hexo that unless it gets its $0.63 share price hiked back up to $1 or more, it's at risk of being delisted from the Nasdaq.

Yahoo | February 1, 2022

Jefferies issues bullish note on buy-rated OrganiGram, upgrades Cronos and Hexo and cuts Tilray’s price target

Jefferies upgraded two Canadian cannabis stocks on Thursday and reduced his price target on a third, remaining most bullish on buy-rated OrganiGram Holdings Inc., which it said is "really starting to hit its stride."

Yahoo | January 27, 2022

Canadian pot company Fire & Flower seeking Nasdaq listing

Fire & Flower Holdings Corp. said it has filed to list its stock on the Nasdaq as the latest Canadian pot company to trade on a major U.S. exchange after Tilray , Canopy Growth , Aurora Cannabis , Cronos Group , OrganiGram Holdings and others. "Listing on the Nasdaq will allow us to expand our shareholder base and drive increased shareholder value as we continue to leverage our unique technology-driven business model to enter new targeted markets across North America," Fire & Flower CEO Trevor Fencott said in a statement on Wednesday. The company said it would announce when its stock will officially start trading on the Nasdaq and did not yet disclose its Nasdaq ticker symbol. OTC-listed shares of Fire & Flower are up 4% so far in 2022 and down 44% in the past 12 months, compared to a l...

MarketWatch | January 20, 2022


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.9198 seconds.